M. Duclos

576 total citations
5 papers, 418 citations indexed

About

M. Duclos is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, M. Duclos has authored 5 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Hematology. Recurrent topics in M. Duclos's work include Rheumatoid Arthritis Research and Therapies (3 papers), Spondyloarthritis Studies and Treatments (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). M. Duclos is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (3 papers), Spondyloarthritis Studies and Treatments (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). M. Duclos collaborates with scholars based in France, Switzerland and United States. M. Duclos's co-authors include M. Luc, Sandra Guignard, Laure Gossec, Adeline Ruyssen‐Witrand, Carine Salliot, Maxime Dougados, Maxime Dougados, H. Zeidler, H. H. Peter and Werner J. Pichler and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Journal of Applied Toxicology.

In The Last Decade

M. Duclos

5 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Duclos France	5	301	104	94	92	77	5	418
M. Luc France	5	294 1.0×	75 0.7×	94 1.0×	92 1.0×	110 1.4×	9	423
Kerry Gallagher United States	9	269 0.9×	79 0.8×	147 1.6×	240 2.6×	83 1.1×	13	496
Sandra Guignard France	10	423 1.4×	117 1.1×	99 1.1×	150 1.6×	125 1.6×	21	604
Olcay Aydıntuğ Türkiye	11	231 0.8×	95 0.9×	102 1.1×	79 0.9×	28 0.4×	20	426
Süleyman Özbek Türkiye	11	128 0.4×	51 0.5×	56 0.6×	34 0.4×	55 0.7×	26	305
N. Ortego Spain	8	226 0.8×	75 0.7×	234 2.5×	41 0.4×	30 0.4×	23	456
J. Lόpez-Longo Spain	10	365 1.2×	96 0.9×	17 0.2×	70 0.8×	65 0.8×	18	471
S. Bucciarelli Spain	8	323 1.1×	61 0.6×	19 0.2×	166 1.8×	40 0.5×	9	414
M. Debandt France	8	300 1.0×	186 1.8×	17 0.2×	145 1.6×	42 0.5×	12	547
B. Louzir Tunisia	9	163 0.5×	102 1.0×	25 0.3×	20 0.2×	47 0.6×	78	326

Countries citing papers authored by M. Duclos

Since Specialization

Citations

This map shows the geographic impact of M. Duclos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Duclos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Duclos more than expected).

Fields of papers citing papers by M. Duclos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Duclos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Duclos. The network helps show where M. Duclos may publish in the future.

Co-authorship network of co-authors of M. Duclos

This figure shows the co-authorship network connecting the top 25 collaborators of M. Duclos. A scholar is included among the top collaborators of M. Duclos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Duclos. M. Duclos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Duclos, M., et al.. (2020). Nonclinical safety assessment of repeated administration and biodistribution of ChAd3‐EBO‐Z Ebola candidate vaccine. Journal of Applied Toxicology. 40(6). 748–762. 7 indexed citations

2.

Ruyssen‐Witrand, Adeline, Laure Gossec, Carine Salliot, et al.. (2007). Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers.. PubMed. 25(3). 430–6. 93 indexed citations

3.

Guignard, Sandra, Laure Gossec, Carine Salliot, et al.. (2006). Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Annals of the Rheumatic Diseases. 65(12). 1631–1634. 163 indexed citations

4.

Salliot, Carine, Laure Gossec, Adeline Ruyssen‐Witrand, et al.. (2006). Infections during tumour necrosis factor- blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients. Lara D. Veeken. 46(2). 327–334. 117 indexed citations

5.

Duclos, M., et al.. (1982). Characterisation of blood and synovial fluid lymphocytes from patients with rheumatoid arthritis and other joint diseases by monoclonal antibodies (OKT series) and acid ?-naphthyl esterase staining. Rheumatology International. 2(2). 75–82. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact